1. Home
  2. MBIO vs CETX Comparison

MBIO vs CETX Comparison

Compare MBIO & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • CETX
  • Stock Information
  • Founded
  • MBIO 2015
  • CETX 1998
  • Country
  • MBIO United States
  • CETX United States
  • Employees
  • MBIO N/A
  • CETX N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • CETX EDP Services
  • Sector
  • MBIO Health Care
  • CETX Technology
  • Exchange
  • MBIO Nasdaq
  • CETX Nasdaq
  • Market Cap
  • MBIO 4.7M
  • CETX 4.3M
  • IPO Year
  • MBIO N/A
  • CETX 1998
  • Fundamental
  • Price
  • MBIO $1.72
  • CETX $5.02
  • Analyst Decision
  • MBIO
  • CETX
  • Analyst Count
  • MBIO 0
  • CETX 0
  • Target Price
  • MBIO N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • MBIO 105.9K
  • CETX 139.1K
  • Earning Date
  • MBIO 11-07-2025
  • CETX 08-14-2025
  • Dividend Yield
  • MBIO N/A
  • CETX N/A
  • EPS Growth
  • MBIO N/A
  • CETX N/A
  • EPS
  • MBIO N/A
  • CETX N/A
  • Revenue
  • MBIO N/A
  • CETX $76,095,551.00
  • Revenue This Year
  • MBIO N/A
  • CETX $19.77
  • Revenue Next Year
  • MBIO N/A
  • CETX $15.00
  • P/E Ratio
  • MBIO N/A
  • CETX N/A
  • Revenue Growth
  • MBIO N/A
  • CETX 16.50
  • 52 Week Low
  • MBIO $0.89
  • CETX $4.81
  • 52 Week High
  • MBIO $21.95
  • CETX $845.25
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 58.12
  • CETX 75.19
  • Support Level
  • MBIO $1.54
  • CETX $5.03
  • Resistance Level
  • MBIO $1.63
  • CETX $5.56
  • Average True Range (ATR)
  • MBIO 0.08
  • CETX 0.36
  • MACD
  • MBIO 0.01
  • CETX 0.44
  • Stochastic Oscillator
  • MBIO 75.50
  • CETX 81.13

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: